Atlas Trials

A Multi-Center Trial to Determine the Safety and Efficacy of LX1033 in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome

Clinical trial NCT01494233 · COMPLETED

Trial details

NCT number
NCT01494233
Sponsor
Lexicon Pharmaceuticals
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Irritable Bowel Syndrome
Start date
2012-02-01
Primary completion
2013-09-01
Enrollment
373

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.